Daré Bioscience, Inc.
DARE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $16 | $10 | $35 | $52 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $1 | $2 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $6 | $7 | $2 |
| Total Curr. Assets | $18 | $18 | $43 | $55 |
| Property Plant & Equip (Net) | $3 | $2 | $1 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $4 | $4 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $22 | $21 | $44 | $56 |
| Liabilities | – | – | – | – |
| Payables | $1 | $3 | $2 | $2 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $17 | $14 | $18 | $11 |
| Other Curr. Liab. | $3 | $3 | $11 | $3 |
| Total Curr. Liab. | $22 | $20 | $32 | $16 |
| LT Debt | $1 | $1 | $0 | $0 |
| Deferred Rev, NC | $1 | $1 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $5 | $4 | $0 | $0 |
| Total NC Liab. | $7 | $6 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $0 | $0 |
| Total Liabilities | $28 | $26 | $33 | $17 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$175 | -$171 | -$141 | -$110 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $170 | $167 | $153 | $149 |
| Total Equity | -$6 | -$5 | $11 | $39 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $22 | $21 | $44 | $56 |
| Net Debt | -$14 | -$9 | -$34 | -$51 |